• The Pistoia Alliance’s Releases Latest Unified Data Model

    Bio-IT World  The Pistoia Alliance yesterday released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS). V6 delivers a stable foundation for the collection and exchange of reaction data and empowers the community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. As increased adoption of AI and ML in R&D continues, such industry-wide data standards are essential in the move toward the digitally driven Lab of the Future (LoTF).

    Feb 26, 2020

  • A Deep Look At The Future Of Medicine

    Bio-IT World  Cardiologist Eric Topol, author of the Creative Destruction of Medicine and The Patient Will See You Now has often written about medicine and technology. But Deep Medicine isn’t just about technology.

    Feb 26, 2020

  • New Players Take the Field: How Private Employer Healthcare Could Mean More Focus on People

    Bio-IT World Contributed Commentary | Depending on which side of the gurney you find yourself, the U.S. healthcare system can be simultaneously viewed as either a modern-day gold rush or an impossible financial burden. In large part, this is because humans have been displaced by business objectives as the focal point of healthcare. If you’re seeking some sign of restored equilibrium between massive healthcare corporations (59 of the S&P 500 companies are healthcare-related) and the individuals they are meant to serve, there’s an inkling of real change, growing out of an unlikely corner… other massive corporations. 

    Feb 25, 2020

  • MGI Announces April Availability Of Sequencers, Reagents In US

    Bio-IT World MGI, part of global genomics leader BGI Group, announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s own innovative CoolMPS sequencing chemistry, starting in April of this year.

    Feb 21, 2020

  • The Value Of Imaging Data As The Missing Essential Component Of Real World Data

    Bio-IT World Contributed Commentary | Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).

    Feb 20, 2020

  • Follow the Money: Big Investments In CRISPR, Cell Therapies, Health Data Management

    Bio-IT World | Some big investments are driving CRISPR-based therapeutics, cell therapies, sepsis diagnostics and more this year. Unspecified investments by pharma are further propelling Seqster’s health data management platform.

    Feb 19, 2020

  • 2020 Open Access Award Finalists Named

    Bio-IT World Bioinformatics.org today announced the finalists in the 2020 Benjamin Franklin Award for Open Access in the Life Sciences. Voting is open to Bioinformatics.org members, and will be open until Friday, February 28. The winner will be announced at the 2020 Bio-IT World Conference & Expo.

    Feb 17, 2020

  • NicheNet: New Tool For Decoding Intercellular Communication

    Bio-IT World | A new bioinformatics method couples Google’s most famous search result ranking algorithm with a parameter optimization technique powered by machine learning to give researchers a better picture of intercellular communication—including the effects of extracellular signals (called ligands) on the gene expression of other cells. 

    Feb 14, 2020

  • AbbVie’s Fresh Look At How AI And Quantum Computing Will Transform Biotech

    Bio-IT World | AbbVie's head of artificial intelligence and senior principal data scientist within the R&D Information Research group argues our innovations must produce value, operational first, then analytic, and finally experiential.

    Feb 11, 2020

  • Scaling Precision Oncology

    Bio-IT World | Kenna Mills-Shaw believes that precision oncology is neither an illusion nor a panacea. But while there have been some dramatic wins for specific, molecularly-defined tumors, scaling precision oncology will require a highly integrated decision support platform.

    Feb 7, 2020

  • Nature Begins Publishing Peer Reviews

    Bio-IT World | Nature Research announced yesterday that its flagship publication, Nature, will join others in the family in publishing peer review correspondence.

    Feb 6, 2020

  • How Wearables Will Help Us Keep Tabs On The Future Of Health

    Bio-IT World | In 2012, Michael Snyder created an integrative personal omics profile, an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual. Today, Snyder is incorporating data from smart watches, continuous glucose monitoring, and other wearables to track people’s health and find early signs of disease.

    Feb 6, 2020

  • Data Storage and Transport: Headaches and Possible Remedies

    Bio-IT World | As organizations generate ever-growing amounts of data, finding ways to overcome the related difficulties of storing, moving, and managing that flood of information remains a central issue.

    Feb 5, 2020

  • Will Research In Space Make Science Fiction Come True?

    Bio-IT World | Orbital Transports is positioning itself as the purveyor of the services and supplies needed in an emerging space-based economy. The immediate goal is an online marketplace for everything one might need to execute a small satellite mission, including life science companies looking to do disease modeling and conduct pharmaceutical and regenerative medicine research.

    Feb 3, 2020

  • NIH’s Moonshot Project To Globally Register Medicinal Ingredients

    Bio-IT World | What’s in a name? When it comes to ingredients found in medicine, quite a lot of important detail. That’s why NIH’s NCATS (National Center for Advancing Translational Sciences) has been working to marshal a definitive resource for medicinal ingredients.

    Jan 31, 2020

  • The Jackson Laboratory, Benchling, Genomenon, And More: News From January 2020

    Bio-IT World January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including the Jackson Laboratory, Benchling, Genomenon, and more.

    Jan 30, 2020

  • Google Cloud To Host Accenture’s INTIENT Life Sciences Platform

    Bio-IT World Accenture and Google Cloud today announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT life sciences industry platform.

    Jan 28, 2020

  • A Computer Scientist Reports On Life In Pharma R&D

    Bio-IT World | “I think that pharma R&D is a fascinating place for a computer scientist to work!” So says Felipe Albrecht, Bioinformatics and Computer Scientist, Pharma Research and Early Development (pRED), at Roche Diagnostics GmbH. Albrecht is a data scientist at heart, believing that data drives all science. And his degrees are all in computer science. But when it came to applying that passion, he turned to molecular biology.

    Jan 27, 2020

  • Leveraging the Power of Data and Collaboration to Change Healthcare

    Bio-IT World Contributed Commentary | Recently David Levine had the opportunity to participate in a Congressional Briefing with Phillip K. Chang, Chief Medical Officer at the University of Kentucky Healthcare; Patricia Garcia Sullivan, Chief Quality Officer at Penn Medicine; and Congressman Brett Guthrie (KY-02). The briefing revealed how data, quantitative analytics, best practices, and empirical metrics are affecting real change across an ever-evolving healthcare landscape.

    Jan 24, 2020

  • Building A Commons: How Bristol-Myers Squibb And BioTeam Used Gen3 To Build A New Data Paradigm

    Bio-IT World | Bristol-Myers Squibb wanted a fundamental change in how the big pharma approached data. They wanted a tool that ensured authentication and authorization, while empowering users to find well-characterized data they need, and a catalog all of the applications, tools, and analyses in use. With help from BioTeam, they found a solution in a custom Gen3 data commons.

    Jan 22, 2020